Science Explorer Back to mapMap
Discussion
Company · Birmingham · United States

DiscoveryBioMed (United States)

discoverybiomed.comROR OpenAlex
Research works
34
▲ 248% vs 2018-21
Citations
488
14.3 per fractional work
Top-10% rate
13.4%
all institutions 10.0%
Open access
63%
world 40%
International
27%
world 18%
DiscoveryBioMed (United States)

Not ranked overall: DiscoveryBioMed (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does DiscoveryBioMed (United States) work in?

In all years, 48% of research at DiscoveryBioMed (United States) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (40%), Biochemistry, Genetics and Molecular Biology (13%), Engineering (9%). It does 1.8× the world's share of Health Sciences.

Health Sciences: 16 fractional works · 47.8% of its workMedicine: 14 fractional works · 40.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 6.4% of its workEpidemiology: 2 fractional works · 4.9% of its workOncology: 2 fractional works · 4.5% of its workPhysiology: 2 fractional works · 4.5% of its workNeurology: 1 fractional works · 2.6% of its workInfectious Diseases: 1 fractional works · 2.2% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 2.0% of its workSurgery: 1 fractional works · 1.9% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.8% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 1.8% of its workPathology and Forensic Medicine: 0 fractional works · 1.1% of its workEmergency Medicine: 0 fractional works · 1.0% of its workRehabilitation: 0 fractional works · 1.0% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.8% of its workOphthalmology: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.6% of its workNephrology: 0 fractional works · 0.5% of its workOtorhinolaryngology: 0 fractional works · 0.5% of its workUrology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workGastroenterology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workVeterinary: 1 fractional works · 3.3% of its workSmall Animals: 1 fractional works · 3.3% of its workHealth Professions: 1 fractional works · 2.8% of its workGeneral Health Professions: 1 fractional works · 2.4% of its workSpeech and Hearing: 0 fractional works · 0.3% of its workDentistry: 0 fractional works · 1.0% of its workPeriodontics: 0 fractional works · 1.0% of its workNursing: 0 fractional works · 0.6% of its workNutrition and Dietetics: 0 fractional works · 0.6% of its workLife Sciences: 9 fractional works · 25.9% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 12.6% of its workMolecular Biology: 2 fractional works · 6.1% of its workPhysiology: 1 fractional works · 2.4% of its workCancer Research: 1 fractional works · 2.3% of its workGenetics: 0 fractional works · 1.4% of its workBiotechnology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 2 fractional works · 5.4% of its workImmunology: 2 fractional works · 4.8% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 2 fractional works · 5.0% of its workInsect Science: 1 fractional works · 2.1% of its workPlant Science: 0 fractional works · 1.2% of its workAquatic Science: 0 fractional works · 0.8% of its workAnimal Science and Zoology: 0 fractional works · 0.6% of its workAgronomy and Crop Science: 0 fractional works · 0.2% of its workNeuroscience: 1 fractional works · 2.9% of its workNeurology: 0 fractional works · 1.2% of its workCognitive Neuroscience: 0 fractional works · 1.0% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSensory Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 6 fractional works · 17.8% of its workEngineering: 3 fractional works · 8.6% of its workCivil and Structural Engineering: 1 fractional works · 3.4% of its workBiomedical Engineering: 1 fractional works · 3.0% of its workBuilding and Construction: 0 fractional works · 1.0% of its workElectrical and Electronic Engineering: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.2% of its workComputer Science: 1 fractional works · 2.9% of its workArtificial Intelligence: 0 fractional works · 1.0% of its workComputational Theory and Mathematics: 0 fractional works · 0.8% of its workInformation Systems: 0 fractional works · 0.6% of its workComputer Networks and Communications: 0 fractional works · 0.5% of its workEnvironmental Science: 1 fractional works · 2.0% of its workEcology: 0 fractional works · 0.7% of its workEnvironmental Chemistry: 0 fractional works · 0.5% of its workGlobal and Planetary Change: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.4% of its workMaterials Science: 1 fractional works · 1.5% of its workBiomaterials: 0 fractional works · 1.0% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 0.5% of its workChemistry: 0 fractional works · 1.3% of its workSpectroscopy: 0 fractional works · 0.7% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workPhysics and Astronomy: 0 fractional works · 1.0% of its workAstronomy and Astrophysics: 0 fractional works · 0.5% of its workStatistical and Nonlinear Physics: 0 fractional works · 0.5% of its workMathematics: 0 fractional works · 0.5% of its workStatistics and Probability: 0 fractional works · 0.5% of its workSocial Sciences: 3 fractional works · 8.5% of its workSocial Sciences: 2 fractional works · 5.9% of its workEducation: 1 fractional works · 4.0% of its workLaw: 1 fractional works · 2.0% of its workBusiness, Management and Accounting: 0 fractional works · 1.3% of its workStrategy and Management: 0 fractional works · 1.0% of its workManagement Information Systems: 0 fractional works · 0.3% of its workDecision Sciences: 0 fractional works · 0.8% of its workStatistics, Probability and Uncertainty: 0 fractional works · 0.5% of its workManagement Science and Operations Research: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.5% of its workClinical Psychology: 0 fractional works · 0.5% of its workALL ITS WORKDiscoveryBioMed(United States)34fractional works, all years
Life Sciences26%Physical Sciences18%Health Sciences48%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 20 fields, with their numbers
    1. Medicine1440.2%
    2. Veterinary13.3%
    3. Health Professions12.8%
    4. Dentistry01.0%
    5. Nursing00.6%
    1. Biochemistry, Genetics and Molecular Biology412.6%
    2. Immunology and Microbiology25.4%
    3. Agricultural and Biological Sciences25.0%
    4. Neuroscience12.9%
    1. Engineering38.6%
    2. Computer Science12.9%
    3. Environmental Science12.0%
    4. Materials Science11.5%
    5. Chemistry01.3%
    6. Physics and Astronomy01.0%
    7. Mathematics00.5%
    1. Social Sciences25.9%
    2. Business, Management and Accounting01.3%
    3. Decision Sciences00.8%
    4. Psychology00.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 1.10× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.94× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 5.41× its world share, 1 worksImmunology and Micro…Neuroscience: 0.56× its world share, 0 worksNeuroscienceChemistry: 1.31× its world share, 0 worksChemistryEngineering: 0.23× its world share, 0 worksEngineeringEnvironmental Science: 0.22× its world share, 0 worksEnvironmental ScienceMaterials Science: 1.20× its world share, 0 worksMaterials ScienceHealth Professions: 1.04× its world share, 0 worksHealth ProfessionsMedicine: 2.18× its world share, 5 worksMedicineVeterinary: 47.77× its world share, 1 worksVeterinaryPsychology: 0.45× its world share, 0 worksPsychologySocial Sciences: 0.32× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 47.8×. Every wedge is a field page.

All 13 fields, with their numbers
  1. Veterinary47.77×1 works
  2. Immunology and Microbiology5.41×1 works
  3. Biochemistry, Genetics and Molecular Biology3.94×3 works
  4. Medicine2.18×5 works
  5. Chemistry1.31×0 works
  6. Materials Science1.20×0 works
  7. Agricultural and Biological Sciences1.10×1 works
  8. Health Professions1.04×0 works
  9. Neuroscience0.56×0 works
  10. Psychology0.45×0 works
  11. Social Sciences0.32×0 works
  12. Engineering0.23×0 works
  13. Environmental Science0.22×0 works

What are the most cited papers from DiscoveryBioMed (United States)?

The most cited paper from DiscoveryBioMed (United States) is "Impact of patient volume on the mortality rate of adult intensive care unit patients" (Laurent G. Glance, Yue Li, Turner M. Osler et al., 2006), with 107 citations. Next come "SPECIFIC INTRAVENOUS CARBOHYDRATE THERAPY A NEW CONCEPT IN INHIBITING ANTIBODY-MEDIATED REJECTION—EXPERIENCE WITH ABO-INCOMPATIBLE CARDIAC ALLOGRAFTING IN THE BABOON" (104) and "Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases" (84).

Most cited papers
#PaperReleasedCitations
1 Impact of patient volume on the mortality rate of adult intensive care unit patients Laurent G. Glance, Yue Li, Turner M. Osler et al. · Critical Care Medicine 18 May 2006 107
2 SPECIFIC INTRAVENOUS CARBOHYDRATE THERAPY A NEW CONCEPT IN INHIBITING ANTIBODY-MEDIATED REJECTION—EXPERIENCE WITH ABO-INCOMPATIBLE CARDIAC ALLOGRAFTING IN THE BABOON David K. C. Cooper, Y. YE, Marek Niekrasz et al. · Transplantation Oct 1993 104
3 Small-molecule allosteric activators of PDE4 long form cyclic AMP phosphodiesterases Faisa Omar et al. · Proceedings of the National Academy of Sciences Open access 17 Jun 2019 84
4 Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54 Steven Mark Rowe, Peter A. Sloane, Li Ping Tang et al. · Journal of Molecular Medicine Open access 21 Jul 2011 73
5 Alterations in glutathione pool and some related enzymes in leaves and roots of pea plants treated with the herbicide glyphosate L. Miteva, Sergei Ivanov, V. Alexieva · Russian Journal of Plant Physiology 2010 65
All 39 most cited papers, with filters and sorting

Which keywords describe research at DiscoveryBioMed (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Immunotherapy, Diabetes Mellitus, Neuroprotection, Tumor Microenvironment, Inflammation, Hypertension and Translational Research.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 15 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 15 words, with their numbers
  1. Epidemiology4▲ 3.3×22 topics
  2. Inflammation2▲ 2.7×11 topics
  3. Immunotherapy2▲ 7.6×7 topics
  4. Diabetes Mellitus1▲ 18×4 topics
  5. Neuroprotection1▲ 11×4 topics
  6. Tumor Microenvironment1▲ 11×5 topics
  7. Clinical Trials1▲ 5.5×3 topics
  8. Hypertension1▲ 10×3 topics
  9. Translational Research1▲ 94×2 topics
  10. Gut Microbiota1▲ 9.3×5 topics
  11. Immune Response1▲ 5.3×4 topics
  12. Management1▲ 4.1×3 topics
  13. Treatment1▲ 2.5×6 topics
  14. Cancer1▲ 2.1×5 topics
  15. Oxidative Stress1▲ 1.64×4 topics

Which research topics does DiscoveryBioMed (United States) publish most on?

By volume in 2022-now: Veterinary Medicine and Surgery, Cancer Genomics and Diagnostics, Veterinary Oncology Research and Biomedical Ethics and Regulation.

Veterinary Medicine and Surgery: 1 fractional worksCancer Genomics and Diagnostics: 1 fractional worksVeterinary Oncology Rese…1Veterinary Oncology Research: 1 fractional worksBiomedical Ethics and Re…0Biomedical Ethics and Regulation: 0 fractional worksGut microbiota and health: 0 fractional worksStroke Rehabilitation and Recovery: 0 fractional worksCAR-T cell therapy resea…0CAR-T cell therapy research: 0 fractional worksImmune Cell Function and Interaction: 0 fractional worksPain Mechanisms and Treatments: 0 fractional worksCRISPR and Genetic Engineering: 0 fractional works
Small AnimalsCancer ResearchPulmonary and Respiratory MedicinePhysiology4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Veterinary Medicine and Surgery Small Animals 1 works
  2. 2 Cancer Genomics and Diagnostics Cancer Research 1 works
  3. 3 Veterinary Oncology Research Pulmonary and Respiratory Medicine 1 works
  4. 4 Biomedical Ethics and Regulation Physiology 0 works
  5. 5 Gut microbiota and health Molecular Biology 0 works
  6. 6 Stroke Rehabilitation and Recovery Rehabilitation 0 works
  7. 7 CAR-T cell therapy research Oncology 0 works
  8. 8 Immune Cell Function and Interaction Immunology 0 works
  9. 9 Pain Mechanisms and Treatments Physiology 0 works
  10. 10 CRISPR and Genetic Engineering Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available62.7%not open37.3%

World: 40% of research is openly available.

with international co-authors27.1%domestic only72.9%

World: 18% is written across borders.

How has DiscoveryBioMed (United States)'s research output changed?

Output in 2022-2025 was 248% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is DiscoveryBioMed (United States) as a percentage of every work published that year, 0.000069% in 2024.

still counting0.000050%0.00010%0.00015%DiscoveryBioMed (United States)0.000069% in 2025200020102020

Fractional works of DiscoveryBioMed (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Birmingham

All research institutions in Birmingham

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about DiscoveryBioMed (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.